GSS
GENETICSIG FPO [GSS]
Healthcare · ASX Small Cap
$0.1000 +0.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 3 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical41
Catalyst50
Sentiment50
Fundamental82
Momentum27
Risk Gate50
Active Signals
Bullish Signals
- RSI oversold (potential bounce)
- Stochastic oversold
- Sustained volume spike (5.5x median) on DOWN trend
- Near support level (potential bounce)
- Sharp 5-day decline (-20.0%)
- Adequate cash runway (7 quarters)
- Low P/S ratio (1.1x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (0% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (55%)
- Severe 12-1 momentum decline (-72%)
- Poor risk-adjusted momentum (Sharpe -1.6)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-57%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE 1H FY26 Results Presentation
NONE 1H FY26 Results Release
NONE 1H FY26 Appendix 4D and Half Year Report
Recent ASX Announcements
| 2026-02-25 | 1H FY26 Results Presentation PRICE SENSITIVE |
| 2026-02-25 | 1H FY26 Results Release PRICE SENSITIVE |
| 2026-02-25 | 1H FY26 Appendix 4D and Half Year Report PRICE SENSITIVE |
| 2026-02-18 | 1H FY26 Results and Investor Webinar Notification |
| 2026-02-10 | Notification of cessation of securities - GSS |
Key Metrics
$22.7M
Market Cap
215K
Avg Volume
5.5x
Vol Ratio
$0.10 — $0.69
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-22.9%
ROE
-56.7%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 74% |
| L | Leader vs Laggard | laggard | RS: -13 |
| I | Institutional Sponsorship | pass | Inst: 55% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #93 of 119 · Sector avg: 51
View all Healthcare signals →